Matthew Balk - Net Worth and Insider Trading
Matthew Balk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Balk owns 2 companies in total, including Entero Therapeutics Inc (ENTO) , and Quantrx Biomedical Corp (QTXB) .
Click here to see the complete history of Matthew Balk’s form 4 insider trades.
Insider Ownership Summary of Matthew Balk
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ENTO | Entero Therapeutics Inc | 2016-10-11 | 10 percent owner |
QTXB | Quantrx Biomedical Corp | 2007-03-09 | 10 percent owner |
Matthew Balk Trading Performance
Matthew Balk Ownership Network
Ownership Network List of Matthew Balk
Ownership Network Relation of Matthew Balk

Matthew Balk Owned Company Details
What does Entero Therapeutics Inc do?
Who are the key executives at Entero Therapeutics Inc?
Matthew Balk is the 10 percent owner of Entero Therapeutics Inc. Other key executives at Entero Therapeutics Inc include Chief Financial Officer Sarah Romano , director & President and CEO James Sapirstein , and CHIEF FINANCIAL OFFICER Daniel H Schneiderman .
Entero Therapeutics Inc (ENTO) Insider Trades Summary
Over the past 18 months, Matthew Balk made no insider transaction in Entero Therapeutics Inc (ENTO). Other recent insider transactions involving Entero Therapeutics Inc (ENTO) include a net sale of 3,117 shares made by Sarah Romano , and a net sale of 3,516 shares made by James Sapirstein .
In summary, during the past 3 months, insiders sold 0 shares of Entero Therapeutics Inc (ENTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,633 shares of Entero Therapeutics Inc (ENTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,633 shares.
Entero Therapeutics Inc (ENTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entero Therapeutics Inc Insider Transactions
Matthew Balk Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Balk. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew Balk's mailing address is: New York Ny 10023.